Tag: metastatic colorectal cancer

23andMe and Genentech Expand Cancer Study

Last year 23andMe and Genentech launched an online study of metastatic breast cancer to learn more about what role genes might play in how a person responds to bevacizumab, also known as Avastin®. (Avastin® is not approved by the FDA for treatment of metastatic breast cancer.) We were happy with the ...

Read more

Return to top